Lexaria Bioscience Files Q1 2026 10-Q
Ticker: LEXX · Form: 10-Q · Filed: Apr 13, 2026
Sentiment: neutral
Topics: 10-Q, quarterly-report, bioscience
Related Tickers: LEXX
TL;DR
LEXX filed its 10-Q for Feb 28, 2026. Check financials.
AI Summary
Lexaria Bioscience Corp. filed its quarterly report (10-Q) on April 13, 2026, for the period ending February 28, 2026. The filing includes financial statements and other disclosures required for public companies. The company's business address is 100 - 740 McCurdy Road, Kelowna, BC V1X 2P7.
Why It Matters
This filing provides investors with an update on Lexaria Bioscience Corp.'s financial performance and operational status for the recent quarter, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a 10-Q filing, it represents standard quarterly reporting for a public company, but the inherent risks of the bioscience sector and specific company performance are not detailed here.
Key Numbers
- 939096 — FORM 10-Q iXBRL Size (Size of the main 10-Q filing document in bytes.)
- 784106 — EXTRACTED XBRL INSTANCE DOCUMENT Size (Size of the extracted XBRL instance document in bytes.)
Key Players & Entities
- Lexaria Bioscience Corp. (company) — Filer of the 10-Q
- 0001348362 (company) — CIK number for Lexaria Bioscience Corp.
- 2026-04-13 (date) — Filing date of the 10-Q
- 2026-02-28 (date) — Period of report for the 10-Q
- 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 (location) — Business and Mailing Address
FAQ
What is the CIK number for Lexaria Bioscience Corp.?
The CIK number for Lexaria Bioscience Corp. is 0001348362.
On what date was this 10-Q filing accepted by the SEC?
This 10-Q filing was accepted on 2026-04-13.
What period does this quarterly report cover?
This quarterly report covers the period ending 2026-02-28.
What is the company's business address?
The company's business address is 100 - 740 McCurdy Road, Kelowna, BC V1X 2P7.
What is the SIC code for Lexaria Bioscience Corp.?
The SIC code for Lexaria Bioscience Corp. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 13, 2026 regarding Lexaria Bioscience Corp. (LEXX).